Trials / Active Not Recruiting
Active Not RecruitingNCT06546800
SPECIAL INVESTIGATION FOR ABRYSVO IN INDIVIDUALS AGED 60 YEARS OR OLDER
SPECIAL INVESTIGATION FOR ABRYSVO INTRAMUSCULAR INJECTION -INVESTIGATION IN INDIVIDUALS AGED 60 YEARS OR OLDER-
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,100 (estimated)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 60 Years
- Healthy volunteers
- Accepted
Summary
This post-marketing study is a multicenter cohort study in individuals aged 60 years or older vaccinated with Abrysvo (RSV vaccine）designed to confirm the safety in individuals aged 60 years or older under actual clinical practice in Japan.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | RSVpreF vaccine | Injection in the muscle, 1 dose 0.5mL |
Timeline
- Start date
- 2025-05-27
- Primary completion
- 2027-10-28
- Completion
- 2027-10-28
- First posted
- 2024-08-09
- Last updated
- 2026-02-04
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT06546800. Inclusion in this directory is not an endorsement.